Catalyst Wire Dossier Catalyst Wire Dossier

Flumazenil (transdermal)

flumazenil
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flumazenil (transdermal), covering 2023-01-10 to 2023-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm [Phase 1, Phase 2]

See pricing